Posted on 11/29/16
Trumpcare Could Be a Disaster for America's Healthcare System -- Here's Why
IMAGE SOURCE: GETTY IMAGES.Are the Affordable Care Act's days numbered? According to the campaign talk of President-elect Donald Trump, it's just a matter of time before . . .
Posted on 11/24/16
Lupus Research Alliance Inaugural Gala Honors Founding Board & Pfizer
The newly merged Lupus Research Alliance celebrated its debut at the Inaugural Gala, uniting the three world leaders in lupus research as the driving force for . . .
Posted on 11/24/16
Taro Announces New $250 Million Share Repurchase Authorization
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that its Board of Directors has approved a new $250 million share repurchase authorization of its ordinary . . .
Posted on 11/23/16
Bellerophon Therapeutics Announces $12 Million Public Offering
WARREN, N.J., Nov. 23, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced the pricing of a public offering with expected . . .
Posted on 11/22/16
Trumpcare Could Be a Disaster for America's Healthcare System -- Here's Why
IMAGE SOURCE: GETTY IMAGES.Are the Affordable Care Act's days numbered? According to the campaign talk of President-elect Donald Trump, it's just a matter of time before . . .
Posted on 11/21/16
Better Buy: Celgene Corporation vs. Bristol-Myers Squibb
Celgene (NASDAQ:CELG) and Bristol-Myers Squibb (NYSE:BMY) have gained plenty of attention recently as great healthcare value plays. My colleague Sean Williams included both stocks in his . . .
Posted on 11/21/16
Better Buy: Regeneron Pharmaceuticals, Inc. vs. Novartis
Both Regeneron Pharmaceuticals (NASDAQ:REGN) and Novartis (NYSE:NVS) have had better years. However, both drugmakers also have reasons to remain optimistic about the future. Which of these . . .
Posted on 11/21/16
Is Pfizer Rethinking a Company Spin-Off?
IMAGE SOURCE: GETTY IMAGES.Pfizer's (NYSE:PFE) stock jumped last week based on a Reuters report that the company could be planning to unload its consumer health unit . . .
Posted on 11/21/16
5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them
Medicare spends billions of dollars each year on prescription drugs. That's not surprising. What might be surprising, though, is how much the federal healthcare program spends . . .
Posted on 11/21/16
Neurotrope Announces Private Placement of $20 Million
Neurotrope, Inc. (OTCQB:NTRP), a company focused on developing drugs to treat neurodegenerative diseases including Alzheimer's disease, today announced that it entered into a definitive securities purchase . . .
Posted on 11/21/16
McCann Named 'Global Healthcare Agency Network of the Year'
McCann Health, winner of this year's Cannes Lions Health Network of the Year, was named 'Global Healthcare Agency Network of the Year' at the 2016 Global . . .
Posted on 11/21/16
Immunomedics Comments on Receipt of Director Nominations
MORRIS PLAINS, N.J., Nov. 18, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU) confirmed that venBio Select Advisor LLC has submitted a notice of nomination of four . . .
Posted on 11/18/16
Motif Bio Prices $25 Million U.S. IPO and European Placing
NEW YORK, Nov. 18, 2016 (GLOBE NEWSWIRE) -- Motif Bio plc (Motif)(NASDAQ:MTFB), a clinical stage biopharmaceutical company specializing in developing novel antibiotics, today announced the pricing . . .
Posted on 11/17/16
Bristol-Myers Squibb's (BMY) Management Presents at Stifel 2016 Health Care Conference (Transcript)
Bristol-Myers Squibb Company (NYSE:BMY)Stifel 2016 Health Care ConferenceNovember 16, 2016 09:30 AM ETExecutivesCharles Bancroft - CFOAnalystsKatherine Breedis - StifelKatherine BreedisI'm Katherine Breedis, Stifel Major Pharma and . . .
Posted on 11/17/16
The Scariest Thing About Pfizer's Dividend
For Pfizer (NYSE:PFE) shareholders who have come to count on steady dividends, there's one frightening thing that jumps out at anyone who looks: the dividend payout . . .
Posted on 11/17/16
Alexion Receives NASDAQ Notification
NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced that it received a notification letter on November 15, 2016 from The NASDAQ Stock Market. The . . .
Posted on 11/17/16
UTHealth, Purdue Pharma Enter Long-Term Research & Education Alliance
HOUSTON and STAMFORD, Conn.--(BUSINESS WIRE)--The University of Texas Health Science Center at Houston(UTHealth) and Purdue Pharma L.P. have entered into a specialized alliance to bring academic . . .
Posted on 11/16/16
MTBC Named in Deloitte's 2016 Technology Fast 500
MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), one of the fastest growing technology companies in the U.S., today announced that it has been named in Deloitte's Technology Fast . . .
Posted on 11/16/16
Merck KGaA's (MKGAF) CEO Walter Galinat on Q3 2016 Results - Earnings Call Transcript
Merck KGaA (OTCPK:MKGAF) Q3 2016 Earnings Conference Call October 16, 2014 10:00 AM ETExecutivesConstantin Fest – Head-Investor RelationsMarcus Kuhnert – Chief Financial OfficerWalter Galinat – Chief . . .
Posted on 11/16/16
Here's How Bed Bath & Beyond Is Looking To Increase Store Traffic
Reports suggest that Bed Bath & Beyond (NASDAQ:BBBY) will serve wine and beer to its customers at its new 120,000 square foot store with a restaurant, . . .
Posted on 11/16/16
Better Buy: Johnson & Johnson vs. Merck
If you owned shares of either Johnson & Johnson (NYSE:JNJ) or Merck (NYSE:MRK) over the last five years, you're likely a happy camper. Both stocks are . . .
Posted on 11/16/16
Go for It, Pfizer -- Sell Your Consumer Healthcare Business
If at first you don't sell or spin off, try, try again.In September, Pfizer (NYSE:PFE) announced that it had decided not to split its legacy drug . . .
Posted on 11/16/16
Better Buy: Biogen Inc. vs. Celgene Corporation
This year might have started off poorly for biotech stocks, but things have certainly changed after the surprising election results. Two of the biggest biotechs around, . . .
Posted on 11/15/16
Matinas BioPharma Reports 2016 Third Quarter Financial Results and Provides Corporate Update
BEDMINSTER, N.J., Nov. 15, 2016 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc.(OTCQB:MTNB), a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective broad spectrum . . .
Posted on 11/15/16
AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders
ALBANY, N.Y., Nov. 14, 2016 (GLOBE NEWSWIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular . . .
New York
